Cargando…

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease

OBJECTIVES: A randomized, parallel controlled, open-label clinical trial was conducted to evaluate the effect of a botanic compound berberine (BBR) on NAFLD. METHODS: A randomized, parallel controlled, open-label clinical trial was conducted in three medical centers (NIH Registration number: NCT0063...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Hong-Mei, Xia, Ming-Feng, Wang, Yan, Chang, Xin-Xia, Yao, Xiu-Zhong, Rao, Sheng-Xiang, Zeng, Meng-Su, Tu, Yin-Fang, Feng, Ru, Jia, Wei-Ping, Liu, Jun, Deng, Wei, Jiang, Jian-Dong, Gao, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529214/ https://www.ncbi.nlm.nih.gov/pubmed/26252777 http://dx.doi.org/10.1371/journal.pone.0134172

Ejemplares similares

Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
por: Chang, Xinxia, et al.
Publicado: (2016)

Berberine in Non-Alcoholic Fatty Liver Disease—A Review
por: Koperska, Anna, et al.
Publicado: (2022)

Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease
por: Xia, Ming-Feng, et al.
Publicado: (2016)

The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
por: Zhu, Xiaopeng, et al.
Publicado: (2016)

Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway
por: Lu, Zengsheng, et al.
Publicado: (2020)

Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
por: Huang, Xin-Juan, et al.
Publicado: (2023)

The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet
por: Chang, Xin-xia, et al.
Publicado: (2012)

Effects of berberine on pharmacokinetics of midazolam and rhodamine 123 in rats in vivo
por: Xin, Hua-Wen, et al.
Publicado: (2016)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
por: Ren, Sichen, et al.
Publicado: (2021)

Plant-based diets, genetic predisposition and risk of non-alcoholic fatty liver disease
por: Lv, Yanling, et al.
Publicado: (2023)

Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
por: Yuan, Xinlu, et al.
Publicado: (2015)

Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2/ARE signalling pathway
por: Deng, Yuanjun, et al.
Publicado: (2019)

Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat
por: Jiang, Wei, et al.
Publicado: (2016)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis
por: Wei, Xiaoyun, et al.
Publicado: (2016)

Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis
por: Qi, Hui-wei, et al.
Publicado: (2014)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota
por: Yang, Sa, et al.
Publicado: (2022)

Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease
por: Chen, Ling-Yan, et al.
Publicado: (2021)

A potential link between polycystic ovary syndrome and non-alcoholic fatty liver disease: an update meta-analysis
por: Wu, Jia, et al.
Publicado: (2018)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

Electrospun polyvinyl butyral/berberine membranes for antibacterial air filtration
por: Qin, Mei, et al.
Publicado: (2021)

Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients
por: Wang, Bairong, et al.
Publicado: (2021)

Suppression of Berberine and Probiotics (in vitro and in vivo) on the Growth of Colon Cancer With Modulation of Gut Microbiota and Butyrate Production
por: Huang, Chao, et al.
Publicado: (2022)

Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice
por: Chen, Yi, et al.
Publicado: (2021)

Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
por: Yang, Jia-Min, et al.
Publicado: (2019)

Berberine displays antitumor activity in esophageal cancer cells in vitro
por: Jiang, Shu-Xian, et al.
Publicado: (2017)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
por: Dong, Yuan, et al.
Publicado: (2022)

Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls
por: Ye, Qing, et al.
Publicado: (2016)

Atheroprotective Effects and Molecular Mechanism of Berberine
por: Xing, Lu, et al.
Publicado: (2021)

The impact of pre-existed and SERM-induced non-alcoholic fatty liver disease on breast cancer survival: a meta-analysis
por: Wang, Changjun, et al.
Publicado: (2020)

Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
por: Stice, Camilla P., et al.
Publicado: (2018)

Association between Non-Alcoholic Fatty Liver Disease and Intracerebral Hemorrhage
por: Tu, Sheng, et al.
Publicado: (2019)

High alcohol-producing Klebsiella pneumoniae causes fatty liver disease through 2,3-butanediol fermentation pathway in vivo
por: Li, Nan-Nan, et al.
Publicado: (2021)

Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
por: Wang, Xiaoxiao, et al.
Publicado: (2021)

Study progress of berberine for treating cardiovascular disease
por: Xia, Le-Min, et al.
Publicado: (2016)

Therapeutic Potential of Natural Plants Against Non-Alcoholic Fatty Liver Disease: Targeting the Interplay Between Gut Microbiota and Bile Acids
por: Sun, QinMei, et al.
Publicado: (2022)

Caveolin-1 Alleviates Acetaminophen—Induced Hepatotoxicity in Alcoholic Fatty Liver Disease by Regulating the Ang II/EGFR/ERK Axis
por: Xin, Jiao, et al.
Publicado: (2022)

Modulation of gut microbiota mediates berberine‐induced expansion of immuno‐suppressive cells to against alcoholic liver disease
por: Li, Sha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ju917hq8h17abn0thcobogqnm9